Product details
The BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B provides fast, accurate identification of COVID-19 and influenza A/B in a single testing workflow. Manufactured by BD, this system supports timely clinical decision-making during respiratory illness seasons and outbreaks.
Utilizing digital immunoassay technology, the BD Veritor™ System delivers clear, objective results to reduce interpretation variability commonly associated with visually read rapid tests. The combined assay helps clinicians quickly differentiate between SARS-CoV-2 and influenza, enabling appropriate patient management and infection control measures.
Designed for point-of-care settings, this system is well suited for physician offices, urgent care centers, clinics, emergency departments, and outpatient facilities, helping streamline workflows and improve testing efficiency.
Key Features:
-
Rapid detection of SARS-CoV-2, influenza A, and influenza B
-
Single workflow supports differential diagnosis of respiratory illness
-
Digital immunoassay technology for objective result interpretation
-
Fast turnaround to support timely treatment and isolation decisions
-
Optimized for point-of-care clinical environments
The BD Veritor™ Plus System is a handheld device that enables testing for Flu A+B, Group A Strep, and respiratory syncytial virus (RSV) assays. One-button functionality and workflow flexibility allow the healthcare team to confidently use the device. In addition, the system’s fast and accurate results may help improve the patient experience. The BD Veritor™ Plus System streamlines the point-of-care testing experience.
